Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on May 15, 2015. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pink Sheet Advertisements

Closed
1148450Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

NAICS

511120 - Periodical Publishers

Place of Performance

Contractor Site, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Anthony S. WimbushContracting Officer
Denise M. McKissickSr. Contract Specialist

Full Description

Show more
NOTICE OF INTENT TO SOLE SOURCE Requisition No. 1148450 NAICS Code: 511120 Informa Business Information, Inc. 1 Research Drive, Suite 400A Westborough, MA 01581-3988 The U.S. Food and Drug Administration (FDA), Office of Acquisitions & Grants Services (OAGS), intends to negotiate and award on a sole source basis to INFORMA BUSINESS INFORMATION, INC., under the authority of FAR 6.302-1, to conduct a series of two (2) daily on-line and print advertisements (via Pink Sheet and Scrip publications) for the CDER-Small Business and Industry Assistance's (CDER SBIA) Regulatory Education of Industry (REdI): Generic Drugs Forum, to be held in June and September 2015. These services are to support the FDA's Center for Drug Evaluation and Research (CDER) in promoting the event. The objective of this procurement is to maximize attendance at the Forum, both domestically and internationally. CDER SBIA's target audience is the global pharmaceutical industry. Given the high readership of the Pink Sheet and Scrip publications, INFORMA BUSINESS INFORMATION, INC., is uniquely positioned to provide news and information to the biopharma and medical device professionals, both domestically (Pink Sheet) and internationally (Scrip). No other organization in the industry can provide the global presence required to promote the Forum. A determination that the proposed price is fair and reasonable will be made in accordance with FAR 13.106-3. Interested parties may identify in writing their interest and capability to respond. Responses must be received by no later than 4:30 PM, Eastern Time, Wednesday, May 28, 2015. If the FDA identifies no other capable sources by that day and time, a Firm-Fixed-Price Purchase Order will be issued to INFORMA BUSINESS INFORMATION, INC. Any inquiries should be directed to Anthony S. Wimbush at 5630 Fishers Lane, Rockville, MD 20857, Room 2103, or via e-mail at anthony.wimbush@fda.hhs.gov; or to Denise McKissick at 5630 Fishers Lane, Rockville, MD 20857, Room 2132, or via e-mail at denise.mckissick@fda.hhs.gov. Posted May 15, 2015 This notice of intent is not a Request for Quotations (RFQ).

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS